🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Immunosuppression

Unravelling the Measles Paradox (MISIA) NCT07267585n/a1 site📍 Rotterdam Erasmus Medical Center Advanced Therapies for Liver Metastases NCT04622423n/a1 site📍 Milan IRCCS San Raffaele Pathological Myeloid Activation After Sepsis and Trauma NCT05616130n/a1 site📍 Gainesville University of Florida · Tests: Data Collection, Bone marrow collection and blood collection, Serial interviews to complete surveys and questionnaires,… Immunosuppression and COVID-19 Boosters NCT05415267Phase 35 sites📍 Blacktown📍 Camperdown📍 Concord Kirby Institute · Tests: diphtheria and tetanus toxoids (adsorbed) vaccine, COVID-19 vaccine Registry of Vaccine Responses in Immune Compromised Patients NCT06463119n/a1 site📍 Geneva Laure Pittet, MD-PhD · Tests: Collection of data in a registry Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction NCT05086003Phase 21 site📍 Petah Tikva Rabin Medical Center · Tests: Combined kidney and bone marrow transplantation CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy NCT07443826Phase 1, Phase 21 site📍 Coxen Hole Unlimited Biotechnology LLC · Tests: AAV9-Follistatin gene therapy, VEGF Plasmid Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia NCT05426252Phase 1, Phase 21 site📍 Toronto The Hospital for Sick Children · Tests: Abatacept, Sirolimus Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years NCT06646497Phase 226 sites📍 Paris📍 Amiens📍 Angers Assistance Publique - Hôpitaux de Paris · Tests: Allogeneic hematopoietic stem cell transplantation Stem cell source only Bone Marrow Quantifying Systemic Immunosuppression to Personalize Cancer Therapy NCT05621837n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: MDSC quantification Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation NCT06809075NA1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: hematopoietic precursor transplantation (TPHa) Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial. NCT06568549Phase 43 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Mycophenolate Mofetil (MMF) Maintenance Group, Mycophenolate Mofetil (MMF) Withdrawal Group This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction NCT06853223Phase 21 site📍 San Francisco University of California, San Francisco · Tests: Maraviroc, Placebo Role of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast Cancer NCT07808086n/a1 site📍 Pavia Istituti Clinici Scientifici Maugeri SpA Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE) NCT07111195n/a5 sites📍 Alicante📍 Barcelona📍 Murcia Juan M Garcia-Gomez · Tests: The ONCOhabitats software for MRI-based habitat segmentation Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease NCT07384897NA1 site📍 Brussels Université Catholique de Louvain · Tests: Peripheral Blood Collection for Immune Profiling Immune Tolerance Induction After Liver Transplantation NCT07269041Phase 1, Phase 21 site📍 Los Angeles University of California, Los Angeles · Tests: Donor Hematopoietic Stem and Progenitor Cell Infusion Early Severe Illness TrAnslational BioLogy InformaticS in Humans NCT05591924n/a1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Phelebotomy, Broncheoalveolar Lavage, Tracheal Aspirate, Rectal Swab Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations NCT05089604Phase 41 site📍 Vancouver University of British Columbia · Tests: Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release Oral Tablet Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY) NCT06354179Phase 418 sites📍 Besançon📍 Clichy📍 Dijon University Hospital, Limoges · Tests: XR-tacrolimus QD + MMF BID then MMF QD, XR-tacrolimus QD + MMF BID, LCP-tacrolimus QD + MMF QD then MMF QD, LCP-tacroli… TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation NCT06829719NA4 sites📍 Bordeaux (France)📍 Lyon📍 Strasbourg (france) Hospices Civils de Lyon · Tests: TTV DNAemia, EQ-5D-5L questionnaire, Biological tests Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD NCT07184853NA1 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Ruxolitinib (JAKAVI®), Etanercept (Enbrel) Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis) NCT01568697n/a1 site📍 Bethesda National Institute of Dental and Craniofacial Research (NID… Impact of Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS) on the Respiratory Physiology in Patients With Prolonged Mechanical Ventilation NCT07002710n/a1 site📍 Taipei National Taiwan University Hospital Immune Biomarkers for Predicting Complications After Liver Transplantation NCT07875595n/a3 sites📍 Pilar📍 Buenos Aires📍 Buenos Aires Hospital Italiano de Buenos Aires · Tests: Immune Biomarker Assessment Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS NCT05814432Phase 35 sites📍 Goiânia📍 Natal📍 Porto Alegre Federal University of Health Science of Porto Alegre · Tests: Single high dose of liposomal amphotericin B, L-AmB standard dose Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD NCT07491523n/a1 site📍 Pátrai University of Patras · Tests: Antifibrotic drugs (nidanib or pirfenidone), MMF Immunosuppression Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies NCT03818334Phase 2, Phase 31 site📍 São Paulo Hospital Israelita Albert Einstein · Tests: Cyclophosphamide, ATG Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression NCT06774235Phase 323 sites📍 Angers📍 Argenteuil📍 Belfort University Hospital, Limoges · Tests: Interferon Gamma 1-b, Placebo Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression NCT05126849Phase 235 sites📍 Amiens📍 Angers📍 Besançon Assistance Publique - Hôpitaux de Paris · Tests: Allogenic transplantation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy